Evaluation of the plasma quality after filtration

Por Mahmoodian Shooshtari, M., Mousavi Hosseini, K.
Publicado em 2010

On the consistency of seismically imaged lower mantle slabs

Por Shephard, G. E., Matthews, K. J., Hosseini, K., Domeier, M.
Publicado no Sci Rep (2017)

A 12‐week DBPC dose‐finding study with sublingual monomeric allergoid tablets in house dust mite‐allergic patients

Por Hüser, C., Dieterich, P., Singh, J., Shah‐Hosseini, K., Allekotte, S., Lehmacher, W., Compalati, E., Mösges, R.
Publicado no Allergy (2016)

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis

Por Pfaar, O., Lang, S., Pieper‐Fürst, U., Astvatsatourov, A., Gerich, F., Klimek, L., Kramer, M. F., Reydelet, Y., Shah‐Hosseini, K., Mösges, R.
Publicado no Allergy (2017)

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy

Por Mösges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G., Shamji, M. H.
Publicado no Allergy (2017)

Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium

Por Duncan, K G, Hosseini, K, Bailey, K R, Yang, H, Lowe, R J, Matthes, M T, Kane, J P, LaVail, M M, Schwartz, D M, Duncan, J L
Publicado em 2009

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients

Por Mösges, R., Koch, A. F., Raskopf, E., Singh, J., Shah‐Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R., Shamji, M. H.
Publicado no Allergy (2018)